• 200mg Tablets
• Indicated for Cushing's Syndrome 

• 10mg/1ml vial for injection
  • Approved for treating obesity caused by LEPR or POMC deficiency in people 6 years and over in line with NICE and any associated NHSE Commissioning Guidance
  • Approved for treating obesity and hyperphagia in Bardet-Biedl syndrome in people 6 years and over, only if they are between 6 and 17 years when treatment starts in line with NICE and any associated NHSE Commissioning Guidance

• 150 mg solution for infusion

Not approved, in line with NICE guidance for treating neuronal ceroid lipofuscinosis type 2